Evergreen Nephrology, a leader in value-based kidney care, announces it has raised $130 million in capital to expand its care model to more patients living with kidney disease. Funding was led by Rubicon Founders, Oak HC/FT and a group of existing investors, with the addition of K2 HealthVentures. Funding will fuel Evergreen’s growth by enabling its expansion into new regions while implementing advanced technologies to improve clinical outcomes, streamline care delivery, and ease the administrative burden on nephrologists. “The healthcare system has long overlooked the critical need to empower nephrologists in the delivery of advanced kidney care management,” said Matt Kim, Partner at Rubicon and Co-Founder of Evergreen Nephrology.
Read the full article: Evergreen Nephrology Raises $130M to Transform and Expand Access to Value-Based Kidney Care //
Source: https://www.prnewswire.com/news-releases/evergreen-nephrology-raises-130-million-to-transform-and-expand-access-to-value-based-kidney-care-302344770.html